Trade

with

DaVita HealthCare Partners Inc
(NYSE: DVA)
US Markets Open
AdChoices
72.89
+0.14
+0.19%
After Hours :
-
-
-

Open

72.70

Previous Close

72.75

Volume (Avg)

835 (865.44k)

Day's Range

72.89-72.89

52Wk Range

52.75-74.84

Market Cap.

-

Dividend Rate ( Yield )

-

Beta

0.69

Shares Outstanding

214.80M

P/E Ratio (EPS)

- (3.15)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Care
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 11.76B

    • Net Income

    • 633.45M

    • Market Cap.

    • -

    • Enterprise Value

    • 22.94B

    • Net Profit Margin %

    • 5.54

    • PEG (Price/Earnings Growth) Ratio

    • 0.38

    • Beta

    • 0.69

    • Forward P/E

    • 17.57

    • Price/Sales

    • 1.28

    • Price/Book Value

    • 3.26

    • Price/Cash flow

    • 8.87

      • EBITDA

      • 2.08B

      • Return on Capital %

      • 3.96

      • Return on Equity %

      • 15.26

      • Return on Assets %

      • 3.96

      • Book Value/Share

      • 22.28

      • Shares Outstanding

      • 214.80M

      • Last Split Factor (Date)

      • 2:1 (9/9/2013)

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Hold
        • 1 Year Price Target

        • 77.00

        • Credit Rating

        • BB

        • Analysts

        • 4

        • EPS Estimate

        • 4.33

        • Cashflow Estimate

        • 6.77

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.80

          • 10.91

          • Net Income

            YTD/YTD (last year)

          • 15.70

          • 13.51

          • Net Income

            Q/Q (last year)

          • -41.90

          • 9.25

          • Sales (Revenue)

            5-Year Annual Average

          • 15.76

          • 22.28

          • Net Income

            5-Year Annual Average

          • 10.60

          • 7.43

          • Dividends

            5-Year Annual Average

          • -

          • 7.69

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 29.55

            • 20.03

            • Pre-Tax Margin

            • 10.34

            • 6.27

            • Net Profit Margin

            • 5.54

            • 3.77

            • Average Gross Margin

              5-Year Annual Average

            • 31.20

            • 20.79

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 11.70

            • 6.01

            • Average Net Profit Margin

              5-Year Annual Average

            • 6.40

            • 210.16B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.75

              • 0.69

              • Current Ratio

              • 1.60

              • 1.48

              • Quick Ratio

              • 1.34

              • 0.75

              • Interest Coverage

              • 3.96

              • 11.79

              • Leverage Ratio

              • 3.75

              • 2.42

              • Book Value/Share

              • 22.28

              • 17.00

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 23.09

                • 23.58

                • P/E Ratio 5-Year High

                • 23.92

                • 103.00

                • P/E Ratio 5-Year Low

                • 8.36

                • 15.89

                • Price/Sales Ratio

                • 1.28

                • 0.83

                • Price/Book Value

                • 3.26

                • 3.21

                • Price/Cash Flow Ratio

                • 8.87

                • 11.03

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 3.26M

                  • Short Ratio

                    as of 9/30/2014

                  • 4.14

                  • Short % of Float

                    as of 9/30/2014

                  • 1.87

                  • Shares Short

                    prior month

                  • 3.37M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • 2:1

                    • Last Split Date

                    • 9/9/2013

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 15.26

                        (19.40)

                      • 12.59

                        (10.63)

                      • Return on Assets %

                        (5-Year Average)

                      • 3.96

                        (4.90)

                      • 6.43

                        (5.79)

                      • Return on Capital %

                        (5-Year Average)

                      • 7.27

                        (8.60)

                      • 8.91

                        (7.75)

                      • Income/Employee

                      • 11.84k

                      • 8.31k

                      • Inventory Turnover

                      • 97.38

                      • 9.85

                      • Asset Turnover

                      • 0.71

                      • 1.70

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      1.55B
                      Operating Margin
                      13.18
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      8.87
                      Ownership

                      Institutional Ownership

                      89.15%

                      Top 10 Institutions

                      45.14%

                      Mutual Fund Ownership

                      29.33%

                      Float

                      81.30%

                      5% / Insider Ownership

                      1.23%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Mid-Cap Index Fund

                      •  

                        3,491,032

                      • 1.38

                      • 1.63

                      • Vanguard Total Stock Mkt Idx

                      •  

                        3,323,536

                      • 0.57

                      • 1.55

                      • T. Rowe Price Capital Appreciation Fund

                      •  

                        2,196,020

                      • 59.80

                      • 1.02

                      • Vanguard Five Hundred Index Fund

                      •  

                        1,783,544

                      • -3.14

                      • 0.83

                      • Vanguard Institutional Index Fund

                      •  

                        1,740,287

                      • -4.38

                      • 0.81

                      • SPDR® S&P 500 ETF

                      •  

                        1,712,513

                      • -1.10

                      • 0.79

                      • Lord Abbett Fundamental Equity

                      •  

                        1,443,471

                      • 83.70

                      • 0.67

                      • AMG TimesSquare Mid Cap Growth Fund

                      •  

                        1,283,500

                      • -2.81

                      • 0.60

                      • Principal LargeCap Growth Fund I

                      •  

                        1,234,319

                      • 0.00

                      • 0.57

                      • CREF Stock

                      •  

                        1,112,477

                      • -1.59

                      • 0.52

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Berkshire Hathaway Inc

                      •  

                        37,621,152

                      • 0.00%

                      • 17.52

                      • Vanguard Group, Inc.

                      •  

                        13,612,114

                      • +1.92%

                      • 6.34

                      • Brown Investment Advisory Incorporated

                      •  

                        8,073,367

                      • -1.84%

                      • 3.76

                      • State Street Corp

                      •  

                        7,582,892

                      • -6.87%

                      • 3.53

                      • GEICO Indemnity Company

                      •  

                        6,795,084

                      • +50.30%

                      • 3.19

                      • TimesSquare Capital Management, LLC

                      •  

                        5,686,201

                      • +2.87%

                      • 2.65

                      • BlackRock Fund Advisors

                      •  

                        5,362,811

                      • +1.15%

                      • 2.50

                      • Egerton Capital LLP

                      •  

                        4,428,669

                      • +24.93%

                      • 2.06

                      • T. Rowe Price Associates, Inc.

                      •  

                        3,885,661

                      • +47.69%

                      • 1.81

                      • Harding Loevner L.P.

                      •  

                        3,815,215

                      • +0.10%

                      • 1.78

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Care

                      Type

                      Aggressive Growth

                      Style

                      Mid Core

                      DaVita HealthCare Partners Inc was incorporated as a Delaware corporation in 1994. It is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease, ...moreor ESRD. The Company also provides administrative and management support services to a medical services joint venture in which the Company owns a 50% interests. It also provides acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. As of December 31, 2013, it provided dialysis and administrative services in the U.S. through a network of 2,074 outpatient dialysis centers in 45 states and the District of Columbia, serving a total of approximately 163,000 patients. It also provides acute inpatient dialysis services in approximatel...morey 1,000 hospitals and related laboratory services throughout the United States. The United States dialysis and related lab services business. Home-based dialysis services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance to patients who prefer and are able to receive either peritoneal dialysis or hemodialysis treatments in their homes. It provides hospital inpatient hemodialysis services are required for patients with acute kidney failure resulting from trauma, patients in early stages of ESRD and ESRD patients who require hospitalization for other reasons. It owns two separately incorporated, licensed, clinical laboratories, both located in Florida, specializing in ESRD patient testing. These specialized laboratories provide routine laboratory tests covered by the Medicare composite payment rate for dialysis and other physician-prescribed laboratory tests for ESRD patients. The Company's laboratories provide these tests predominantly for its own ESRD patients throughout the United States. It currently operates or provides management and administrative services to 29 outpatient dialysis centers, in which it either owns a non-controlling interest, or is wholly-owned by third parties, under management and administrative services agreements. It continues to face increased competition in the dialysis industry from large and medium-sized providers which compete directly with it for acquisition targets as well as for individual patients.lessless

                      Key People

                      Javier Rodriguez

                      CEO, Divisional

                      Kent J. Thiry

                      CEO/Co-Chairman/Director

                      Craig E. Samitt

                      CEO, Divisional

                      Dr. Garry E. Menzel, PhD

                      CFO

                      Ms. Leanne M. Zumwalt

                      Vice President, Divisional

                      • DaVita HealthCare Partners Inc

                      • 1551 Wewatta Street

                      • Denver, VT 80202

                      • USA.Map

                      • Phone: +1 303 405-2100

                      • Fax: +1 310 792-8928

                      • davita.com

                      Incorporated

                      1994

                      Employees

                      57,400

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: